Asahi Kasei (3407) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
15 Apr, 2026Progress toward medium-term management plan targets
On track to achieve FY2027 operating income target of ¥270 billion, driven by growth in Healthcare and AI/semiconductors.
Business portfolio transformation and structural reforms are enabling sustainable growth despite market uncertainties.
Strategic investments and M&A, especially in Healthcare and Electronics, are supporting income growth.
Record-high operating income is forecasted for a second consecutive year in FY2025.
Capital allocation balances growth investments and shareholder returns, with strong operating cash flow.
Vision and sector strategies
Aims for 2030 include operating income of ¥380 billion, ROIC ≥8%, and ROE ≥12%.
Focus on sustainability, carbon neutrality, and digital innovation across Material, Homes, and Healthcare sectors.
Shifting income composition toward high value-added businesses in diverse industries.
Each sector leverages shared resources, technology, and management expertise for growth.
Business portfolio and investment focus
Proactive growth investments and M&A totaling ~¥1 trillion, with ~¥600 billion in capex for growth.
Portfolio prioritizes First Priority (Pharmaceuticals, Overseas Homes, Electronics, Critical Care) and Growth Potential businesses.
Structural transformation in the Material sector, including divestitures and alliances, to improve profitability.
Expansion-related investments focus on First Priority businesses, especially in North America and Japan.
Latest events from Asahi Kasei
- Aicuris acquisition secures a robust infectious disease pipeline, accelerating pharma growth.3407
Acquisition presentation26 Feb 2026 - Record operating income and net income growth, with an upwardly revised full-year forecast.3407
Q3 20264 Feb 2026 - Net income up 10% YoY, full-year profit guidance raised, and dividend maintained.3407
Q2 20265 Nov 2025 - Operating income rose but net income plunged on one-time and extraordinary losses; outlook and dividends improved.3407
Q1 202631 Jul 2025 - Operating and net income surged, but currency losses drove comprehensive income negative.3407
Q2 202513 Jun 2025 - Operating income jumped 128.9% YoY in Q1, with a strong outlook for FY2024.3407
Q1 202513 Jun 2025 - Record profit and acquisitions drive FY 2024; FY 2025 targets growth amid market risks.3407
Q4 20256 Jun 2025 - Profits and sales surged, forecasts raised, and a large share buyback was completed.3407
Q3 20255 Jun 2025